House Judiciary Committee Subpoenas Health Insurers Over ACA Fraud Investigation

On February 10, 2026, the House Judiciary Committee, led by Republican Chair Jim Jordan, issued subpoenas to eight health insurers as part of an investigation into potential fraud related to the Affordable Care Act (ACA) premium subsidies. The insurers targeted include Elevance, CVS, Centene, GuideWell, Oscar Health, Kaiser Permanente, Health Care Service Corporation, and Blue Shield of California. The subpoenas require these companies to provide documents by February 23, 2026, detailing their subsidized ACA enrollees and any discussions regarding subsidy-related fraud.

Reuters

The investigation follows reports from federal auditors indicating that some health insurers had enrolled individuals who do not exist in their subsidized coverage programs. This raised concerns about the integrity of the ACA subsidy system, particularly as millions of Americans face rising insurance costs after the expiration of special COVID-era tax credits. In December 2025, Jordan had initially requested information from these insurers, but the responses received did not meet his expectations, prompting the issuance of subpoenas.

Reuters

• Jim Jordan: Chair of the House Judiciary Committee, leading the investigation into ACA subsidy fraud.

Reuters

• Health Insurers: The eight companies subpoenaed, including major players like CVS and Centene, are central to the inquiry.

Reuters

CVS confirmed receipt of the subpoena and stated that it is cooperating with the investigation. Centene also indicated its willingness to provide information to assist in combating fraud and enhancing access to healthcare. GuideWell expressed its commitment to cooperating with all inquiries related to the investigation.

Reuters

The investigation has drawn criticism from various stakeholders who argue that the focus on health insurers may overlook systemic issues within the ACA framework. Critics contend that the rising costs of insurance premiums are a result of broader economic factors rather than fraud alone. Some health policy experts have expressed concern that the investigation could distract from necessary reforms aimed at improving the ACA.

Reuters

While the House Judiciary Committee has highlighted potential fraud, the specifics of the alleged fraudulent activities remain unclear. There is also a lack of detailed information regarding the extent of the fraud and how it has impacted enrollees. The responses from the insurers have not been publicly disclosed, leading to questions about the transparency of the investigation.

Reuters

The House Judiciary Committee expects to receive the requested documents from the health insurers by February 23, 2026. The outcome of this investigation could have significant implications for the future of the ACA and the regulation of health insurance practices in the United States. Further hearings may follow based on the findings from the submitted documents.

Reuters

• “A GuideWell spokesperson said it has cooperated with all inquiries.” — GuideWell Spokesperson

Reuters